[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Tuesday, 14 February 2006, 08:10 GMT
Glaxo in $50m Croatian drug deal
Glaxo's headquarters in London
Glaxo is Europe's biggest drug maker
GlaxoSmithKline has bought the research institute of Croatian drug maker Pliva in a deal worth up to $50m (28.7m).

Zagreb-based Pliva, eastern Europe's largest drug maker by sales, will get an upfront sum of $35m with possible further payments of up to $15m.

In addition, Pliva will receive royalties on certain assets should they reach the market.

Glaxo, Europe's biggest drug maker, is to take control of Pliva's intellectual property assets and employ its staff.

The deal is expected to be completed in April, subject to regulatory approval.

Pliva opened its newly built state-of-the-art research and development institute in 2002 and focuses on the generic drugs business. It has a target to launch between 60 and 80 new generic products this year.

Glaxo profit up 17% on good sales
08 Feb 06 |  Business
Drug firm profits beat forecasts
27 Oct 05 |  Business
Strong results pep up drug makers
28 Jul 05 |  Business
FDA agreement lifts Glaxo shares
28 Apr 05 |  Business
GSK investors bring Paxil lawsuit
14 Apr 05 |  Business
GSK aims to stop Aids profiteers
21 Feb 05 |  Business

The BBC is not responsible for the content of external internet sites


Americas Africa Europe Middle East South Asia Asia Pacific